INO


The Race Continues for a COVID-19 Vaccine; 3 Healthcare Stocks to Watch

The question keeping the world up at night: when will a COVID-19 vaccine be ready? Since China released the virus’ genetic sequence on …

Inovio Advances COVID-19 Vaccine to Phase 1 Testing; Analyst Reiterates ‘Buy’

Amid the ongoing public health crisis, Wall Street is eagerly awaiting any piece of good news. Inovio Pharmaceuticals (INO) just came through.

3 Biotech Stocks to Watch as the Race for a Coronavirus Vaccine Continues

On your mark, get set, go! The race is on to find an effective vaccine against COVID-19, the novel coronavirus that has spread to 471,000 …

Analysts: 2 Coronavirus Stocks to Buy (And 1 to Avoid)

As record levels of volatility continue to plague the market, investors globally have been left grappling with the economic fallout. After landing in …

It’s Too Early to Tell If Inovio (INO) Is a COVID-19 Play, Says Analyst

The novel coronavirus is dominating headlines around the world right now. But in Maxim Group’s latest report on Inovio Pharmaceuticals (INO), COVID-19 merits …

Inovio Pharmaceuticals’ vaccine for coronavirus could be ready by year’s end

Since news of the coronavirus outbreak emerged, in contrast to the sell-off in the broader market, companies associated with the COVID-19 space have …

This Biotech Stock Moves One Step Closer to a Coronavirus Vaccine; Analyst Says Buy

No need to ask what issue currently sits at the top of global priority “to do” lists. Around the world, the search is …

A Vaccine for Coronavirus? These 3 Healthcare Stocks Are Working on It

Fear and uncertainty have gripped the global population as the number of confirmed coronavirus cases grows daily. What started in Wuhan, the capital …

This Coronavirus Stock Has Over 40% Upside, Say Analysts

Inovio (INO) has had an up-and-down month. Shares shot up nearly 70% by January 27, before slipping 25% in the subsequent two days.

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts